Key terms

About ENVB

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ENVB news

Mar 21 10:52am ET Here’s What You Missed in Cannabis, Psychedelics This Week by TipRanks Mar 19 7:12am ET Enveric Biosciences Explores Joint Disease Treatment Licensing by TipRanks Mar 19 7:10am ET Enveric in out-licensing deal for chemical entities to treat joint diseases by TipRanks Mar 12 7:25am ET USPTO issues patent to Enveric titled ‘Multi-Substituent Psilocybin Derivatives’ by TipRanks Mar 11 12:43pm ET Enveric Biosciences to sell 228,690 shares at $1.41 in direct offering by TipRanks Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week by TipRanks Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week by TipRanks Feb 29 7:38am ET Enveric in compound out-licensing deal with biotech firm with by TipRanks Feb 29 7:14am ET Enveric Biosciences Plans to Out-License Compound Classes by TipRanks Feb 23 8:10am ET Enveric Biosciences to sell cancer-related patent portfolio, terms undisclosed by TipRanks Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week by TipRanks Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week by TipRanks Feb 21 8:23am ET Enveric Biosciences Unveils New Mental Health Compounds by TipRanks Feb 10 4:07am ET Enveric Biosciences Granted Extension to Avoid Nasdaq Delisting by TipRanks Jan 30 6:03am ET Enveric Biosciences initiated with a Buy at H.C. Wainwright by TipRanks Jan 11 4:45pm ET Enveric Biosciences files to sell 2.24M shares of common stock for holders by TipRanks Dec 29 8:57am ET Enveric Biosciences sells 1.122M shares at $1.37 in private placement by TipRanks Dec 28 8:04am ET Enveric Biosciences selects EB-003 as lead in ‘next gen’ EVM301 series by TipRanks Dec 27 8:09am ET Enveric Biosciences reports progress on developing lead prodrug candidate EB-373 by TipRanks

No recent press releases are available for ENVB

ENVB Financials

1-year income & revenue

Key terms

ENVB Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ENVB Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days